Literature DB >> 2257149

Mesoderm induction in Xenopus laevis distinguishes between the various TGF-beta isoforms.

A B Roberts1, P Kondaiah, F Rosa, S Watanabe, P Good, D Danielpour, N S Roche, M L Rebbert, I B Dawid, M B Sporn.   

Abstract

Induction of mesoderm in ectodermal explants of Xenopus laevis blastula embryos had previously been shown to respond selectively to TGF-beta 2, with TGF-beta s 1 and 5 having no activity in this assay. As TGF-beta s 1, 2, and 3 are frequently coexpressed in tissues, we wished to examine the activity of TGF-beta 3 relative to that of TGF-beta s 1 and 2 in this assay as well as in other in vitro assays. We report here that when the activity of recombinant TGF-beta 3 is normalized to that of TGF-beta 1 in the assay for growth inhibition in CCL-64 cells, it is also equal to that of TGF-beta 1 in assays for stimulation of both anchorage-independent growth of rat NRK cells and chemotaxis of human monocytes. In contrast, in the assay for mesoderm induction, recombinant TGF-beta 3 is 10-fold more active than TGF-beta 2, inducing expression of muscle specific alpha-actin at concentrations as low as 1 ng/ml. These results suggest that more complex systems, in contrast to individual cell types, may respond selectively to the various TGF-beta isoforms and that there might be biological consequences of TGF-beta isoform switching in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2257149     DOI: 10.3109/08977199009003670

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  12 in total

1.  Runx2-I is an Early Regulator of Epithelial-Mesenchymal Cell Transition in the Chick Embryo.

Authors:  Andre L P Tavares; Jessie A Brown; Emily C Ulrich; Katerina Dvorak; Raymond B Runyan
Journal:  Dev Dyn       Date:  2017-07-19       Impact factor: 3.780

2.  Identification of a structural domain that distinguishes the actions of the type 1 and 2 isoforms of transforming growth factor beta on endothelial cells.

Authors:  S W Qian; J K Burmester; J R Merwin; J A Madri; M B Sporn; A B Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

3.  Bone morphogenetic proteins-2 and -4 are involved in the retinoic acid-induced differentiation of embryonal carcinoma cells.

Authors:  M B Rogers; V Rosen; J M Wozney; L J Gudas
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

4.  Construction of eukaryotic expression plasmid of hTGF-β3 and its inducing effect on differentiation of precartilaginous stem cells into chondroblasts.

Authors:  Hongbo You; Anmin Chen; Tie Liu; Maopeng Wang; Guoliang Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

5.  Secretion and transcriptional regulation of transforming growth factor-beta 3 during myogenesis.

Authors:  R Lafyatis; R Lechleider; A B Roberts; M B Sporn
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

6.  In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-beta 1: age-related differences.

Authors:  H M van Beuningen; P M van der Kraan; O J Arntz; W B van den Berg
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

7.  cDNA cloning and developmental expression of fibroblast growth factor receptors from Xenopus laevis.

Authors:  R Friesel; I B Dawid
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

Review 8.  Engineering cartilage tissue.

Authors:  Cindy Chung; Jason A Burdick
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

9.  Inhibition of osteogenic differentiation of human mesenchymal stem cells.

Authors:  Eduardo K Moioli; Liu Hong; Jeremy J Mao
Journal:  Wound Repair Regen       Date:  2007 May-Jun       Impact factor: 3.617

10.  Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.

Authors:  S Kojima; K Nara; D B Rifkin
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.